Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000240 · ClinicalTrials.gov registry record · Phase 2
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
A Phase 2 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000240: Completed Phase 2 study, sponsored by University of Vermont.
NCT00000240 is a Phase 2 study that has completed, run by University of Vermont. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000240, a Phase 2 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-04 |
| Phase | Phase 2 |
What the finished NCT00000240 record still lists
NCT00000240 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00000240 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000240 about?
NCT00000240 is a clinical study titled "Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22". The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.
What is the current status of trial NCT00000240?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-04.
What interventions are being tested in trial NCT00000240?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00000240?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia